Fortis Healthcare and SRL Diagnostics, India’s second largest hospital group and largest lab group respectively, are demerging so private equity investors can exit and it can offer specialised hospital and lab stock picks. SRL’s CEO Sanjeev Vashista told Healthcare Nova SRL has eight years left on its contracts with Fortis, which will, in any case, remain a majority shareholder.